Immuron Ltd — Investor Relations & Filings
Filings indexed
1,602
across all filing types
Latest filing
2018-11-19
Foreign Filer Report
Country
AU
Australia
Listing
ASX
IMRN
Immuron Ltd. is a clinical and commercial-stage biopharmaceutical company focused on developing and commercializing a novel class of orally delivered, specifically targeted polyclonal antibodies. The company's proprietary technology platform is based on polyclonal immunoglobulins (IgG) derived from hyper-immune bovine colostrum to address unmet medical needs, primarily related to gastrointestinal and enteric diseases. Its commercialized products include Travelan®, for reducing the risk of travelers' diarrhea, Protectyn®, for supporting gut and liver function, and ProIBS®, for relieving symptoms of Irritable Bowel Syndrome. Immuron's clinical pipeline includes therapeutic candidates for infectious diseases such as Clostridioides Difficile and Vancomycin-Resistant Enterococci.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2018-11-19 | English | |
| FORM 6-K | 2018-11-19 | English | |
| IMC Appoints Experienced US Based Biotech Executive as CEO 3 pages 1.1MB | 2018-11-18 | English | |
| Results of Meeting 1 page 754.1KB | 2018-11-18 | English | |
| FORM 6K | 2018-11-09 | English | |
| NASH clinical trial presentation & continued revenue growth 2 pages 864.8KB | 2018-11-08 | English |
Browse filings by year
25 years- 2026 23 filings
- 2025 142 filings
- 2024 106 filings
- 2023 79 filings
- 2022 70 filings
- 2021 57 filings
- 2020 118 filings
- 2019 134 filings
- 2018 92 filings
- 2017 142 filings
- 2016 59 filings
- 2015 47 filings
- 2014 44 filings
- 2013 57 filings
- 2012 76 filings
- 2011 49 filings
- 2010 47 filings
- 2009 61 filings
- 2008 46 filings
- 2007 45 filings
- 2006 27 filings
- 2005 28 filings
- 2004 30 filings
- 2003 19 filings
- 2002 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 12925299 | FORM 6-K | 2018-11-19 | English | ||
| 12925301 | FORM 6-K | 2018-11-19 | English | ||
| 40831033 | IMC Appoints Experienced US Based Biotech Executive as CEO 3 pages 1.1MB | 2018-11-18 | English | ||
| 40831015 | Results of Meeting 1 page 754.1KB | 2018-11-18 | English | ||
| 12925300 | FORM 6K | 2018-11-09 | English | ||
| 40831043 | NASH clinical trial presentation & continued revenue growth 2 pages 864.8KB | 2018-11-08 | English | ||
| 12925302 | 6-K | 2018-11-01 | English | ||
| 12925304 | 20-F | 2018-10-31 | English | ||
| 40831083 | Annual Report 2018 on Form 20-F & XBRL data filed with SEC 144 pages 2.3MB | 2018-10-31 | English | ||
| 12925305 | 6-K | 2018-10-18 | English | ||
| 12925303 | FORM 6-K | 2018-10-16 | English | ||
| 40831098 | IMC's CEO Interviewed in US on the RedChip Money Report 2 pages 805.2KB | 2018-10-15 | English | ||
| 12925306 | 6-K | 2018-10-11 | English | ||
| 40831123 | Notice of Annual General Meeting/Proxy Form 27 pages 1.4MB | 2018-10-10 | English | ||
| 40831138 | Notice of Annual General Meeting/Proxy Form 26 pages 1.4MB | 2018-10-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Immuron Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35121/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35121 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35121 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35121 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35121}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immuron Ltd (id: 35121)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.